25 Years In, High Tech Medical Forecasts What Business Owners Ought to Invest Their Money In Next

April 2024 marks 25 years since Australasian device distributor High Tech Medical was first registered.

Formally known as High Tech Laser, the company has remained at the forefront of innovation in minimally invasive aesthetic technologies. In its time, High Tech Medical has welcomed a series of globally esteemed devices into the region, such as the likes of CoolSculpting and HydraFacial.

Investments in innovation

Commencing in the dental space, High Tech Medical served as one of the main suppliers of dental lasers in Australia. From there, established relationships with Deka and Fotana saw the company expand into lasers and other energy devices in aesthetic medicine.

In 2007, they launched the first fractional CO2 laser in Australia with the Deka SmartXide Dot, followed by the launch of CoolSculpting, Hydrafacial and MonaLisa Touch, as well as working with globally-recognised brands such as Ulthera, InMode and Ellipse.

High Tech Medical’s Managing Director, Matt Moncrieff expresses pride in High Tech Medical’s achievements as a “well established, reputable, reliable and trusted name within the industry.”

“We provide practitioners with the latest treatments that produce outstanding results with less downtime and less risk in the field of minimally invasive cosmetic medicine. This, combined with our ability to offer customised, integrated solutions to medical and aesthetic professionals throughout Australia and New Zealand, with a very personalised approach, is a great asset,” Matt says.

What’s next?

With investment in so many industry-revered names and technologies, Matt hints the company will strive to bring forward many more industry ‘firsts’. “Over the past 25 years at High Tech Medical, minimally-invasive technologies have evolved exponentially with many ground-breaking innovations being launched along the way.”

“The upward spiral of consumer demand for time-effective, little to no downtime procedures with less risk has been a driving force behind the development of such treatments, like CoolPeel, a 10-minute skin rejuvenation treatment that provides immediate visible results with no need for anaesthetic and no side effects.”

Matt foresees that in the next five years, we should anticipate “a further push towards using new and improved technologies that allow practitioners to provide consumers with better treatment outcomes with less downtime and less risk.”

“I can see combination treatments becoming more prominent with energy-based devices, high-quality skincare and regenerative medicine techniques working together to provide longer-lasting and more natural-looking results.”

From tech to cosmeceuticals

Today, High Tech Medical’s portfolio includes luxury, pharmaceutical-grade cosmeceutical brand, iS Clinical; ultrasound technology, Sofwave; RF technology, EndyMed; EmCyte PRP; Velež Intense Hydration Masks, Black and Black surgical instruments; and game-changing technologies by European manufacturer, Deka.

“We have seen a major shift in consumers seeking optimal treatment outcomes with minimal impact on their daily lives and more recently, the demand for natural-looking results. The same goes for medical-grade cosmeceuticals. Consumer knowledge about skincare and its ingredients has evolved and consumers know the difference between products that provide results vs products that make the claim. Consumers see pharmaceutical-grade cosmeceuticals and minimally invasive treatments as an investment in their skin. They are willing to pay as long as they see results.”

To learn more about High Tech Medical and how the business advises clients to get the best return on investment, read our Autumn 2024 cover story here.

Read the current issue of our digital magazine here:

Have an idea for a story or want to see a topic covered on our site and in our pages? Get in touch at info@professionalbeauty.com.au.

Back to top